Skip to main content

Table 1 Demographic and clinical features of the cohort

From: Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration

Case

MAPT variant

MAPT isoform

Sex

Age onset (yrs)

Age death (yrs)

Disease duration (yrs)

Group

FTLD-CDR

Clinical diagnosis

PMI (hrs)

Brain weight (g)

Co-pathology

1

L315R

3R + 4R

F

 

68

 

Early-stage

0

 

6

1188

Age-related tau (B2)

2

P301L

4R

F

 

59

 

Early-stage

0.5

MCBMIa

6

1079

 

3

G272V

3R

M

43

45

2

Early-stage

1

bvFTD

6

1495

 

4

P301L

4R

M

49

52

3

Intermediate-stage

2

bvFTD

12

1115

 

5

P301L

4R

M

53

55

2

Intermediate-stage

2

bvFTD

4

1100

 

6

G272V

3R

F

47

54

7

Intermediate-stage

2

bvFTD

8

1027

 

7

L315R

3R + 4R

F

54

63

9

End-stage

3

bvFTD

4

758

 

8

L315R

3R + 4R

M

52

57

5

End-stage

3

bvFTD

8

1111

 

9

P301L

4R

M

58

66

8

End-stage

3

bvFTD

5

1011

 

10

P301L

4R

M

39

46

7

End-stage

3

bvFTD

6

1065

 

11

P301L

4R

F

56

66

10

End-stage

3

bvFTD

7

707

 

12

P301L

4R

M

51

60

9

End-stage

3

bvFTD

5

887

 

13

P301L

4R

F

50

64

14

End-stage

3

bvFTD

8

652

 

14

P301L

4R

M

52

64

12

End-stage

3

bvFTD

6

1029

 

15

P301L

4R

M

53

57

4

End-stage

3

bvFTD

5

1197

Vascular (infarcts)b

16

P301L

4R

M

57

65

8

End-stage

3

bvFTD

6

1002

 

17

G272V

3R

F

45

54

9

End-stage

3

bvFTD

6

791

 

18

G272V

3R

F

47

67

20

End-stage

3

bvFTD

4

757

 

19

G272V

3R

M

41

49

8

End-stage

3

bvFTD

5

1188

Beta-amyloid (A1, C0)

20

G272V

3R

M

42

51

9

End-stage

3

bvFTD

4

962

Vascular (ischemic scars)c

21

G272V

3R

M

42

49

7

End-stage

3

bvFTD

5

1105

 
  1. Legend: bvFTD = behavioural variant frontotemporal dementia; FTLD-CDR = global Clinical Dementia Rating plus FTLD NACC; MCBMI = mild cognitive and/or behavioural and/or motor impairment; PMI = postmortem interval
  2. aOnly mild symptoms were present immediately before death, likely consistent with an MCBMI diagnosis. As the patient was not seen clinically during that period, the diagnosis could not be formally ascertained, and the exact age of symptom onset is uncertain (between 50–55 years of age)
  3. bCase 15 showed two small old cortical infarctions in the motor cortex and one small recent cortical infarction in the occipital cortex
  4. cCase 20 had small ischemic scars in the occipital cortex